• 2891 Citations
  • 29 h-Index
1983 …2020
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Oreste Segatto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Epidermal Growth Factor Receptor Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences
NIH 3T3 Cells Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Receptor Protein-Tyrosine Kinases Medicine & Life Sciences
Transducers Medicine & Life Sciences
Phosphorylation Medicine & Life Sciences
TYK2 Kinase Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1983 2020

  • 2891 Citations
  • 29 h-Index
  • 50 Article
  • 1 Chapter
  • 1 Comment/debate
  • 1 Letter

Making sense of Cbp/p300 loss of function mutations in skin tumorigenesis

Anastasi, S., Alemà, S. & Segatto, O., Jan 1 2020, In : Journal of Pathology. 250, 1, p. 3-6 4 p.

Research output: Contribution to journalComment/debate

Open Access
1 Citation (Scopus)

HSP90 Inhibition Drives Degradation of FGFR2 Fusion Proteins: Implications for Treatment of Cholangiocarcinoma

Lamberti, D., Cristinziano, G., Porru, M., Leonetti, C., Egan, J. B., Shi, C. X., Buglioni, S., Amoreo, C. A., Castellani, L., Borad, M. J., Alemà, S., Anastasi, S. & Segatto, O., Jan 2019, In : Hepatology. 69, 1, p. 131-142 12 p.

Research output: Contribution to journalArticle

Open Access

miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling

Migliore, C., Morando, E., Ghiso, E., Anastasi, S., Leoni, V. P., Apicella, M., Cora', D., Sapino, A., Pietrantonio, F., Braud, F. D., Columbano, A., Segatto, O. & Giordano, S., Sep 1 2018, In : EMBO Molecular Medicine. 10, 9, p. 10.15252/emmm.201708746

Research output: Contribution to journalArticle

Protein-Tyrosine Kinases
Therapeutics
Neoplasms
Down-Regulation
RNA

miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling

Migliore, C., Morando, E., Ghiso, E., Anastasi, S., Leoni, V. P., Apicella, M., Cora', D., Sapino, A., Pietrantonio, F., De Braud, F., Columbano, A., Segatto, O. & Giordano, S., Sep 2018, In : EMBO Molecular Medicine. 10, 9

Research output: Contribution to journalArticle

Protein-Tyrosine Kinases
Therapeutics
Neoplasms
Down-Regulation
RNA

Lack of Evidence that CYTH2/ARNO Functions as a Direct Intracellular EGFR Activator

Anastasi, S., Zhu, S. J., Ballarò, C., Manca, S., Lamberti, D., Wang, L. J., Alemà, S., Yun, C. H. & Segatto, O., May 19 2016, In : Cell. 165, 5, p. 1031-1034 4 p.

Research output: Contribution to journalLetter